Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes

Objective. Genital herpes (GH) recurrences and viral shedding are more frequent in the first year after initial HSV-2 infection. The objective of this study was to provide the first evaluation of valacyclovir 1 g once daily compared to placebo in reducing viral shedding in subjects newly diagnosed w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Martens, Mark G., Fife, Kenneth H., Leone, Peter A., Dix, Lynn P., Brennan, Clare A.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2009
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2724712/
https://ncbi.nlm.nih.gov/pubmed/19680456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/105376
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items